iTechGuides is reader-supported. When you buy through links on our site, we may earn an affiliate commission. As an Amazon Associate I earn from qualifying purchases. Learn more
Chronic inflammation can contribute to the development and instability of fatty plaque in artery walls, raising cardiovascular risk over time. It is not, by itself, a guarantee of heart disease: inflammation interacts with factors such as smoking, high blood pressure, and LDL cholesterol, and the pathways vary. The clearest account in current public guidance is how this process affects arteries and can lead to a heart attack or ischemic stroke—not a single, inevitable path to progressive heart-muscle damage.
How inflammation and artery plaque interact
Inflammation is part of the immune system’s response to injury or infection. A short-lived response can help protect the body; chronic inflammation persists for months or years and can harm healthy tissue. The American Heart Association (AHA) explains that cardiovascular risks such as smoking, high blood pressure, and LDL cholesterol can injure artery walls and contribute to atherosclerotic plaque buildup. Immune cells gather at affected areas, where immune activity can interact with blood lipids and contribute to plaque growth or instability.
The National Heart, Lung, and Blood Institute (NHLBI) describes immune danger signals as potentially increasing plaque size and triggering events that can make plaque rupture. These processes are still being studied. The AHA notes that scientists are working to understand where cardiovascular-disease-related inflammation occurs and how immune pathways differ among people. Inflammation is one part of cardiovascular risk, not a standalone explanation or inevitable cause of disease.
The Tool Desk
Outbyte PC Repair FREERepair Windows errors before they cause bigger problemsFix Now →Outbyte Driver Updater FREEScan for outdated or missing drivers - takes under a minuteDriver Scan →Can inflammation cause a heart attack or stroke?
Inflammation can contribute to the arterial plaque process, but a heart attack or ischemic stroke occurs when blood flow is blocked. If plaque or a clot blocks a coronary artery supplying the heart, it can cause a heart attack. If an artery in or leading to the brain is blocked, it can cause an ischemic stroke. These acute events can follow a process that develops over time; chronic inflammation does not mean that either event will necessarily happen.
#1 Best Overall
- Avery publishing group
- Language: english
- Book - prevent and reverse heart disease: the revolutionary, scientifically proven, nutrition-based cure
What about damage to the heart muscle?
The available public sources describe a clearer connection between inflammation, atherosclerosis in artery walls, and cardiovascular events than a universal direct mechanism by which chronic inflammation progressively damages heart muscle. NHLBI discusses heart failure and research into inflammatory pathways, but that does not establish one simple cause-and-effect path for everyone. The effects depend on the underlying condition and the person’s overall cardiovascular risk.
How do doctors measure inflammation related to heart disease?
High-sensitivity C-reactive protein (hsCRP) is a marker associated with cardiovascular risk. An AHA professional toolkit summarizing a 2025 American College of Cardiology scientific statement presents hsCRP assessment alongside cholesterol and clinical management. The toolkit quotes the statement’s recommendation: “Universal screening of hsCRP in both primary and secondary prevention patients, in combination with cholesterol, presents a major clinical opportunity and is therefore recommended.” This is a recommendation reproduced in professional guidance; it is not personal medical advice, and an hsCRP result does not by itself diagnose the cause of inflammation.
Rank #2
What the evidence says about lowering inflammation
An NHLBI feature published November 12, 2024, says lower levels of chronic inflammation “have been shown to curb cardiovascular disease risks in some people by about 20–30%.” The feature does not identify the underlying study or define the population in that sentence, so the figure should not be read as an individual’s expected benefit. The same feature quotes cardiovascular medicine specialist Peter Libby, M.D., of Brigham and Women’s Hospital and Harvard Medical School: “Inflammation is the common theme from the beginning to the end of atherosclerosis and across many conditions.”
Quick wins for a faster PC:
Scan for outdated or missing drivers - takes under a minuteDriver Scan →Repair Windows errors before they cause bigger problemsFix Now →NHLBI also discusses colchicine and other anti-inflammatory approaches as areas of treatment and ongoing research. Choosing a treatment requires clinical judgment about the person, the relevant pathway, and the balance of risks and benefits. Do not start colchicine, a statin, supplements, or another medicine for inflammation without advice from a clinician. AHA guidance emphasizes management of established risks, including smoking, high blood pressure, and LDL cholesterol; addressing inflammation does not replace that care.
Quick Recap
Best Value
Rank #3
Sources
- American Heart Association, “Inflammation and Heart Disease”, last reviewed January 11, 2024.
- National Heart, Lung, and Blood Institute, “Immune function, inflammation, and cardiovascular disease”, November 12, 2024.
- American Heart Association, “hsCRP: Toolkit for Professionals”, summarizing the 2025 ACC scientific statement.
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
